[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 26, Issue 1 (Bimonthly 2022) ::
Feyz 2022, 26(1): 1-8 Back to browse issues page
Anti-nociceptive effect of atomoxetine on paclitaxel-induced neuropathic pain in mice and role of alpha-2 adrenergic receptor
Azam Mesdaghinia , Hamidreza Banafshe , Alireza Moravveji , Ghazal Hajiagajani , Narges Esmaeilian , Alireza Abed *
Physiology Research Center, Kashan University of Medical Sciences, Kashan, I.R. Iran. , arabed1365@gmail.com
Abstract:   (647 Views)
Background: Neuropathic pain due to chemotherapy is one of the most important types of chronic pain that despite the increasing advances in medical sciences, its treatment is associated with many problems. In this study, the effects of atomoxetine on paclitaxel-induced neuropathic pain and the effect of alpha-2 adrenergic receptor antagonist (yohimbine) on the analgesic effect of atomoxetine were researched.
Materials and Methods: Male mice received paclitaxel (2 mg/kg i.p.) from the first to the fifth day and atomoxetine (5, 10, and 15 mg/kg p.o.) was administered from the day 6 to 10. Mice were divided into different groups (n=8) and each group received a unique dose of the drug. On days 9, 10 and 11, Von Frey and acetone tests were performed. Also, the effect of alpha-2 adrenergic receptor antagonist (yohimbine) on the analgesic effect of atomoxetine was investigated. For this purpose, after pain induction, mice received atomoxetine (15 mg/kg p.o) with yohimbine (5 mg/kg i.p. 5) from day 6 to 10.
Results: Daily administration of atomoxetine (15 mg/kg p.o) effectively increased pain threshold in the cold and mechanical allodynia tests (P<0.01). Administration a single dose of atomoxetine on the 11th day did not alter behavioral tests.
Conclusion: According to these findings, it can be concluded that atomoxetine is able to reduce the severity of paclitaxel-induced neuropathic pain.
Keywords: Neuropathic pain, Paclitaxel, Atomoxetine, Allodynia, Mice
Full-Text [PDF 414 kb]   (318 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2021/12/22 | Accepted: 2022/02/23 | Published: 2022/04/4
References
1. St John Smith E. Advances in understanding nociception and neuropathic pain. J Neurol 2018; 265(2): 231-8.
2. Colvin LA. Chemotherapy-induced peripheral neuropathy: where are we now? Pain 2019; 160 Suppl 1(Suppl 1): S1-S10.
3. Schuler U, Heller S. Chemotherapy-induced peripheral neuropathy and neuropathic pain. Schmerz 2017; 31(4): 413-25.
4. Staff NP, Fehrenbacher JC, Caillaud M, Damaj MI, Segal RA, Rieger S. Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems. Exp Neurol 2020; 324: 113121.
5. Sisignano M, Baron R, Scholich K, Geisslinger G. Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nat Rev Neurol 2014; 10(12): 694-707.
6. Fedder D, Patel H, Saadabadi A. Atomoxetine. 2021 Aug 6. In: StatPearls (Internet). Treasure Island [FL]: StatPearls Publishing; 2021 Jan–.
7. Kremer M, Salvat E, Muller A, Yalcin I, Barrot M. Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights. Neuroscience 2016; 338: 183-206.
8. Mika J, Zychowska M, Makuch W, Rojewska E, Przewlocka B. Neuronal and immunological basis of action of antidepressants in chronic pain - clinical and experimental studies. Pharmacol Rep 2013; 65(6): 1611-21.
9. Bahari Z, Meftahi GH. Spinal alpha(2) -adrenoceptors and neuropathic pain modulation; therapeutic target. vBr J Pharmacol 2019; 176(14): 2366-81.
10. Hajhashemi V, Banafshe HR, Minaiyan M, Mesdaghinia A, Abed A. Antinociceptive effects of venlafaxine in a rat model of peripheral neuropathy: role of alpha2-adrenergic receptors. Eur J Pharmacol 2014; 738: 230-6
11. Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 2013; 309(13): 1359-67.
12. Levey AI, Qiu D, Zhao L, Hu WT, Duong DM, Higginbotham L, et al. A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. Brain 2021; awab452
13. Barbaros MB, Can ÖD, Üçel Uİ, Turan Yücel N, Demir Özkay Ü. Antihyperalgesic Activity of Atomoxetine on Diabetes-Induced Neuropathic Pain: Contribution of Noradrenergic and Dopaminergic Systems. Molecules 2018; 23(8): 2072.
14. Naji-Esfahani H, Vaseghi G, Safaeian L, Pilehvarian AA, Abed A, Rafieian-Kopaei M. Gender differences in a mouse model of chemotherapy-induced neuropathic pain. Lab Anim 2016; 50(1): 15-20
15. Abed A, Khoshnoud MJ, Taghian M, Aliasgharzadeh M, Mesdaghinia A. Quetiapine reverses paclitaxel-induced neuropathic pain in mice: Role of alpha2- adrenergic receptors. Iran J Basic Med Sci 2017; 20(11): 1182-8.
16. Hou QX, Yu L, Tian SQ, Jiang CJ, Yang WJ, Wang ZJ. Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats. Iran J Basic Med Sci 2016; 19(3): 272-80.
17. Choi S, Yamada A, Kim W, Kim SK, Furue H. Noradrenergic inhibition of spinal hyperexcitation elicited by cutaneous cold stimuli in rats with oxaliplatin-induced allodynia: electrophysiological and behavioral assessments. J Physiol Sci 2017; 67(3): 431-8.
18. Finnerup NB. Neuropathic pain and spasticity: intricate consequences of spinal cord injury. Spinal Cord 2017; 55(12): 1046-50.
19. Shim HS, Bae C, Wang J, Lee KH, Hankerd KM, Kim HK, Chung JM, La JH. Peripheral and central oxidative stress in chemotherapy-induced neuropathic pain. Mol Pain 2019; 15: 1744806919840098.
20. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010; 9(8): 807-19
21. Finnerup NB, Kuner R, Jensen TS. Neuropathic Pain: From Mechanisms to Treatment. Physiol Rev 2021; 101(1): 259-301.
22. Flatters SJL, Dougherty PM, Colvin LA. Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review. Br J Anaesth 2017; 119(4): 737-49
23. Xu L, Zhang Y, Huang Y. Advances in the Treatment of Neuropathic Pain. Adv Exp Med Biol 2016; 904: 117-29.
24. Bates D, Schultheis BC, Hanes MC, Jolly SM, Chakravarthy KV, Deer TR, et al. A Comprehensive Algorithm for Management of Neuropathic Pain. Pain Med 2019; 20(Suppl 1): S2-S12
25. Obata H. Analgesic Mechanisms of Antidepressants for Neuropathic Pain. Int J Mol Sci 2017; 18(11): 2483
26. [26] Kalkman HO, Feuerbach D. Antidepressant therapies inhibit inflammation and microglial M1-polarization. Pharmacol Ther 2016; 163: 82-93
27. Cottingham C, Ferryman CJ, Wang Q. alpha2 Adrenergic Receptor Trafficking as a Therapeutic Target in Antidepressant Drug Action. Prog Mol Biol Transl Sci 2015; 132: 207-2
28. Deng L, Lee WH, Xu Z, Makriyannis A, Hohmann AG. Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems. Pharmacol Res 2016; 114: 75-89.
29. Katsuyama S, Sato K, Yagi T, Kishikawa Y, Nakamura H. Effects of repeated milnacipran and fluvoxamine treatment on mechanical allodynia in a mouse paclitaxel-induced neuropathic pain model. Biomed Res 2013; 34(2): 105-11.
30. Lu Y, Zhang P, Zhang Q, Yang C, Qian Y, Suo J, et al. Duloxetine Attenuates Paclitaxel-Induced Peripheral Nerve Injury by Inhibiting p53-Related Pathways. J Pharmacol Exp Ther 2020; 373(3): 453-62.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mesdaghinia A, Banafshe H, Moravveji A, Hajiagajani G, Esmaeilian N, Abed A. Anti-nociceptive effect of atomoxetine on paclitaxel-induced neuropathic pain in mice and role of alpha-2 adrenergic receptor. Feyz 2022; 26 (1) :1-8
URL: http://feyz.kaums.ac.ir/article-1-4526-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 26, Issue 1 (Bimonthly 2022) Back to browse issues page
مجله علمی پژوهشی فیض ::: دانشگاه علوم پزشکی کاشان KAUMS Journal ( FEYZ )
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4509